Global Pharmaceutical Contract Manufacturing Market CAGR, Volume and Value 2020

wisguy wisguy

Summary - A new market study, titled “ Global Pharmaceutical Contract Manufacturing Market 2020-2030 by Category, Product (AP…December 01, 2020

Global pharmaceutical contract manufacturing market will reach $184.8 billion by 2030, growing by 6.2% annually over 2020-2030 driven by increasing dependence on contract manufacturing organizations due to improved efficiency and productivity amid COVID-19 pandemic.

Highlighted with 87 tables and 85 figures, this 173-page report “Global Pharmaceutical Contract Manufacturing Market 2020-2030 by Category, Product (API, FDF), Phase (Clinical, Commercial), Type (Sterile, Non-Sterile), Therapeutic Application, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global pharmaceutical contract manufacturing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure

• Growth Drivers

• Restraints and Challenges

• Emerging Product Trends & Market Opportunities

• Porter’s Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global pharmaceutical contract manufacturing market in every aspect of the classification from perspectives of Category, Product, Phase, Type, Therapeutic Application, and Region.

Based on Category, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Pharmaceutical Industry

• Biopharmaceutical Industry

Based on Product, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Active Pharmaceutical Ingredients (API)

• Branded API Manufacturing

• Generic API Manufacturing

Finished Dosage Formulations (FDF)

• Solid Dosage

• Oral Liquids

• Parenteral/Injectables

• Other FDFs

Secondary Packaging

ALSO READ https://www.abnewswire.com/pressreleases/global-pharmaceutical-contract-manufacturing-market-2020-trending-technologies-developments-key-players-and-enduse-industry-to-2030_517991.html

Based on Phase, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Clinical Manufacturing

• Commercial Manufacturing

Based on Type, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Sterile Products

• Non-Sterile Products

Based on Therapeutic Application, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Infectious Diseases

• Oncology

• Metabolic Disorders

• Cardiovascular Disorders

• Central Nervous System

• Pulmonary Disorders

• Gastrointestinal Disorders

• Other Therapeutic Applications

Geographically, the following regions together with the listed national/local markets are fully investigated:

• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)

• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)

• North America (U.S., Canada, and Mexico)

• South America (Brazil, Chile, Argentina, Rest of South America)

• MEA (Saudi Arabia, UAE, South Africa)

For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Product, Phase, and Therapeutic Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in global pharmaceutical contract manufacturing market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):

Aenova Group

Baxter BioPharma Solutions

Boehringer Ingelheim

Catalent Inc.

Famar S.A.

Hospira, Inc.

Jubilant Life Sciences Ltd.

Lonza Group

Patheon Inc.

Pfizer CentreSource

Recipharm AB

Vetter Pharma International GmbH

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

FOR MORE DETAILS https://www.wiseguyreports.com/reports/6013963-global-pharmaceutical-contract-manufacturing-market-2020-2030-by

About Us:

Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

NORAH TRENT

[email protected]

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

wisguy wisguy

Pharmaceutical Contract Manufacturing Market Trends Latest Technology, Emerging Technology till 2027

nilesh 2022-05-06

As per Global Pharmaceutical Contract Manufacturing Market Trends Analysis, the Global Market based companies will face certain challenges during the forecast period 2020 to 2027. On the flip side, lack of manufacturing standardization and capacity utilization of issues are some of the major factors impacting the profitability of pharmaceutical contract manufacturing organizations. By mode of type, the global pharmaceutical contract manufacturing market has been segmented into finished dosage formulation market, active pharmaceutical ingredient manufacturing, and others. Regional InsightsGeographically, the pharmaceutical contract manufacturing market span across regions namely, Asia Pacific, America, Europe, and the Middle East and Africa. com/reports/pharmaceutical-contract-manufacturing-market-1532 About Market Research Future:At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.

Global Pharmaceutical Contract Manufacturing Market Indication, Regions and Forecast 2029

manisha kashid 2023-08-12

com/request-sample/65189 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing market:The Global Pharmaceutical Contract Manufacturing industry has borne the brunt of the COVID-19 pandemic, with profound implications. Industry Trends and Emerging TechnologiesKey Questions Answered in the Global Pharmaceutical Contract Manufacturing Market Report are: Which segment emerged as the leading segment in the Global Pharmaceutical Contract Manufacturing market? What trends are likely to emerge in the Global Pharmaceutical Contract Manufacturing market in the coming years? What will be the Global Pharmaceutical Contract Manufacturing market size by 2027? Which company held the largest share in the Global Pharmaceutical Contract Manufacturing market in 2020?

Contract Pharmaceutical Manufacturing Market: Strategies for Successful Partnerships

gauri kanale 2023-06-15

In the Contract Pharmaceutical Manufacturing Market, transparency and open communication are key elements of successful partnerships. By fostering a collaborative approach, they can align their manufacturing capabilities and resources to meet the unique needs of pharmaceutical companies. This agility allows pharmaceutical companies to respond to market demands quickly and effectively. They demonstrate their commitment to quality, compliance, and continuous improvement through certifications, audits, and performance metrics. html

Global Contract Pharmaceutical Manufacturing Market Is Estimated To Witness High Growth Owing To Increasing Demand for Outsourcing and Technological Advancements

Anjali Pawar 2023-08-17

The global Contract Pharmaceutical Manufacturing Market is estimated to be valued at US$ 178. Moreover, outsourcing enables pharmaceutical companies to access a global network of manufacturing facilities, making it easier to penetrate new markets. This growth is driven by the increasing demand for outsourcing and technological advancements. - Key players operating in the global contract pharmaceutical manufacturing market include Accenture plc, Cognizant Technology Solutions, ATOS SE, Catalent, Inc. The market offers opportunities for pharmaceutical companies to optimize their operations, reduce costs, and access specialized expertise and facilities.

The Growth Of The Global Contract Pharmaceutical Manufacturing Is Accelerated By Increasing Demand For Generics And Biosimilars

kiran gire 2023-12-15

The Contract Pharmaceutical Manufacturing Market involves manufacturing of pharmaceutical drugs and medicines on a contract basis for pharmaceutical companies. The global Contract Pharmaceutical Manufacturing Market is estimated to be valued at US$ 101. Segment Analysis The contract pharmaceutical manufacturing market can be segmented into active pharmaceutical ingredients (APIs), final dosage forms (FDFs), and packaging. Key Takeaways The global contract pharmaceutical manufacturing market scope is expected to witness high growth over the forecast period of 2023 to 2030. Key players operating in the contract pharmaceutical manufacturing market are Accenture plc, ATOS SE, Catalent, Inc.

Pharmaceutical Contract Manufacturing Market Share, Merger, Acquisition, Size Estimation, New Investment Opportunities, Statistics, Overview, and Forecast till 2026

Chetan Khachne 2021-10-22

The global Pharmaceutical Contract Manufacturing market was valued at USD 82430.9 Million in 2018 and is expected to reach USD 144958.8 million by the year 2026, at a CAGR of 7.2%.The pharmaceutical industry uses outsourcing services from providers in the form of contract research organizations (CROs) and contract manufacturing organizations (CMOs).

Pharmaceutical Contract Manufacturing organizations are a response to the competitive international nature of the pharmaceutical market as well as the increasing demand for outsourced services.With the increasing demand for generic formulations and biologics, complex manufacturing requirements, and the capital-intensive nature of the business, many pharmaceutical companies have identified the potential profitability in contracting with a CMO (contract manufacturing outsourcing) for both commercial and clinical stage manufacturing.

Furthermore, pharmaceutical companies have been directing their priorities towards the core areas of competency, and hence, prefer not to dispense available resources, expertise, and technology on formulating the final dose of medicines.

The costs invested in R are increasing, and the useful results returned from these processes are becoming scarcer.

Many manufacturing companies have realized that moving this part of the business overseas and taking advantage of the still-emerging pharmaceutical markets is an effective method of cutting costs.

However, Increasing Lead Time and Logistics Costs and stringent Regulatory Requirements by different nations are expected to hinder the pharmaceutical contract manufacturing market growth Top Companies Profiled in the Report Include:Thermo Fisher Scientific Inc. (US), Catalent, Inc. (US), Lonza Group Ltd (Switzerland), Recipharm AB (Sweden), Vetter Pharma International GMBH (Germany), FAMAR Health Care Services (Greece), AbbVie Inc. (US), Aenova Group (Germany), Consort Medical plc (UK), Almac Group (UK), Siegfried Holding AG (Switzerland), Boehringer Ingelheim International GmbH (Germany), and Evonik Industries AG (Germany).Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2280Market Overview: The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness.

WHO TO FOLLOW